NASDAQ · Key Statistics

SOPHiA GENETICS SA (SOPH) P/E Ratio, ROE & Key Statistics

$7.45 NASDAQ: SOPH Market Cap $634.20M

Data as of Nov 17, 2026 close · Source: Financial Modeling Prep (methodology)

Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for SOPHiA GENETICS SA (SOPH), each with what it measures. Figures are trailing twelve months or the most recent reported period.

Valuation

MetricValue
P/E ratioShare price divided by earnings per share.-6.18
P/B ratioShare price divided by book value per share.8.42
P/S ratioMarket value divided by annual revenue.6.30
PEG ratioP/E divided by the earnings growth rate.-2.82
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.-8.17
EV / RevenueEnterprise value against annual revenue.5.94
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.-14.22%
Free cash flow yieldFree cash flow as a percentage of market value.-8.46%

Profitability

MetricValue
Gross marginRevenue left after the direct cost of goods sold.66.43%
Operating marginRevenue left after operating costs.-80.47%
Net marginRevenue left after every cost, including tax and interest.-89.18%
Return on equityProfit as a percentage of shareholders’ equity.-132.79%
Return on assetsProfit as a percentage of total assets.-43.92%
Return on capital employedOperating profit against the capital the business uses.-56.40%

Financial health

MetricValue
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.2.29
Quick ratioThe same, excluding inventory.2.16
Cash ratioCash alone against current liabilities.1.37
Debt to equityTotal borrowings against shareholders’ equity.0.89
Debt to assetsTotal borrowings against total assets.0.39
Interest coverageHow many times operating profit covers the interest bill.-11.13

Per share and size

MetricValue
Earnings per shareProfit attributable to each share.−$1.17
Market capitalisationShare price times shares outstanding.$634.20M
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.$604.61M
EmployeesReported headcount.423

Dividend

MetricValue
Dividend yieldAnnual dividend as a percentage of the share price.0.00%

SOPHiA GENETICS SA (SOPH) statistics — frequently asked questions

What is SOPHiA GENETICS SA's P/E ratio?

SOPHiA GENETICS SA (SOPH) trades on a price-to-earnings ratio of -6.18. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.

What is SOPHiA GENETICS SA's return on equity?

SOPHiA GENETICS SA (SOPH) reports a return on equity of -132.79%, meaning it generated that much profit for every dollar of shareholders' equity.

How much debt does SOPHiA GENETICS SA carry?

SOPHiA GENETICS SA (SOPH) has a debt-to-equity ratio of 0.89, which compares total borrowings with shareholders' equity.

What is SOPHiA GENETICS SA's profit margin?

SOPHiA GENETICS SA (SOPH) keeps -89.18% of revenue as net profit after every cost, including tax and interest.

P/E and ROE of other Medical - Healthcare Information Services stocks

VEEV P/E 49.97GEHC P/E 19.84BTSG P/E 42.56TEM ROE -40.86%HNGE P/E 58.11HQY P/E 36.60DOCS P/E 44.29HTFL ROE -27.52%PRVA P/E 85.38CERT ROE -6.39%All Medical - Healthcare Information Services stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.